3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
49
Burkitt Lymphoma
27
Leukemia, Biphenotypic, Acute
15
Leukemia, Myeloid, Acute
13
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
10
Leukemia
10
Myelodysplastic Syndromes
9
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
7
Lymphoma
6
Leukemia, Myeloid, Accelerated Phase
6
Blast Crisis
6
Lymphoma, Non-Hodgkin
5
Lymphoma, Mantle-Cell
5
Lymphoma, Large B-Cell, Diffuse
5
Graft vs Host Disease
5
Osteosarcoma
4
Medulloblastoma
4
Down Syndrome
4
Urinary Bladder Neoplasms
3
Recurrence
3
Primary Myelofibrosis
3
Neoplasm Metastasis
3
Myeloproliferative Disorders
3
Leukemia, Myelomonocytic, Juvenile
3
Hematologic Neoplasms
3
Head and Neck Neoplasms
3
Blastic Plasmacytoid Dendritic Cell Neoplasm
3
Thrombocythemia, Essential
2
Rhabdoid Tumor
2
Polycythemia Vera
2
Interventions
fludarabine
5
Cyclophosphamide
5
fludarabine phosphate
4
Whole-Body Irradiation
2
Tacrolimus
2
Peripheral Blood Stem Cell Transplantation
2
Patient Reported Outcome Measures
2
Mycophenolic Acid
2
Mesna
2
Melphalan
2
Busulfan
2
Bendamustine Hydrochloride
2
AP 1903 reagent
2
pembrolizumab
1
isatuximab
1
ibrutinib
1
Lenalidomide
1
Dexamethasone
1
CLR1404
1
CA-4948
1
Bortezomib
1
Bone Marrow Transplantation
1
ARQ531
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Immunoproliferative Disorders
×
Methotrexate
×
1 year
×
Clear all
No trials found.